Antisense - Xconomy

by in

Entry	Author	Date	Location
Roche & Isis Join Forces on Antisense Drug for Huntington’s Disease	Bruce V. Bigelow	04/08/13	San Diego
RNA Therapeutics Are Coming of Age	Kleanthis Xanthopoulos	02/08/13	San Diego
San Diego Life Sciences Roundup: Isis, Afraxis, Organovo, & More	Bruce V. Bigelow	01/31/13	San Diego
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio	Bruce V. Bigelow	12/12/12	San Diego
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes	Stewart Lyman	04/11/12	Seattle
Buyouts, Quantified Health, & More San Diego Life Sciences News	Bruce V. Bigelow	12/01/11	San Diego
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring	Luke Timmerman	11/22/11	San Diego
Isis Nabs $35M Payment From Glaxo	Luke Timmerman	03/31/10	San Diego
Five Biotechnologies That Will Fade Away This Decade	Stephen Friend	01/06/10	National
Isis, Genzyme Use Antisense to Go Where Many Drugs Fail—The Brain	Luke Timmerman	08/05/09	San Diego
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers	Wade Roush	04/29/09	San Diego
Genzyme Places Big Bet on Antisense RNA With Isis Deal	Rebecca Zacks	01/08/08	Boston
RNAi Firms Find a New Rival (and Partner) in an Old Technology	Malorye Allison	10/04/07	Boston
Page 1 of 1

Xconomy National